These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38214677)

  • 21. Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial.
    McCreanor V; Nowbar A; Rajkumar C; Barnett AG; Francis D; Graves N; Boden WE; Weintraub WS; Al-Lamee R; Parsonage WA
    BMJ Open; 2021 Feb; 11(2):e044054. PubMed ID: 33563623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of coronary sinus reducer in patients with refractory angina-A systematic review of the literature.
    Bazoukis G; Brilakis ES; Tse G; Letsas KP; Kitsoulis P; Liu T; Baranchuk A; Sideris A; Tsioufis C; Stavrakis S
    J Interv Cardiol; 2018 Dec; 31(6):775-779. PubMed ID: 30191622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-pharmacological treatment of refractory angina: The coronary sinus reducer, the new kid on the block.
    Madeira S; Brízido C; Raposo L; Brito J; Vale N; Leal S; Gonçalves PA; Gabriel HM; Teles RC; Almeida M
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):371-382. PubMed ID: 34187640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
    Foley M; Rajkumar CA; Shun-Shin M; Ganesananthan S; Seligman H; Howard J; Nowbar AN; Keeble TR; Davies JR; Tang KH; Gerber R; O'Kane P; Sharp ASP; Petraco R; Malik IS; Nijjer S; Sen S; Francis DP; Al-Lamee R
    J Am Heart Assoc; 2021 Feb; 10(3):e017381. PubMed ID: 33496201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary Sinus Reducer for the Treatment of Chronic Refractory Angina: Will This Challenge the Treatment of Coronary Chronic Total Occlusions?
    Vescovo GM; Zivelonghi C; Bellamoli M; Vermeersch P; Verheye S; Agostoni P
    Curr Cardiol Rep; 2021 Mar; 23(4):31. PubMed ID: 33655425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantation of a Coronary Sinus Reducer to Treat Refractory Angina in a 38-Year-Old with an Anomalous Left Coronary Artery and No Revascularization Options.
    Cheng K; de Silva R
    Cardiology; 2020; 145(3):126-129. PubMed ID: 32007999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Innovative therapies for the treatment of refractory angina: the Reducer, a percutaneous device to narrow the coronary sinus].
    Benedetto D; Abawi M; Stella PR; Nijhoff F; Agostoni P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):625-9. PubMed ID: 26571476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [THE CORONARY SINUS REDUCER: A DEVICEBASED THERAPY FOR REFRACTORY ANGINA].
    Konigstein M; Banai S
    Harefuah; 2016 Nov; 155(11):677-681. PubMed ID: 28530070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris.
    Tzanis G; Palmisano A; Gallone G; Ponticelli F; Baldetti L; Esposito A; Colombo A; Giannini F
    Catheter Cardiovasc Interv; 2020 May; 95(6):1104-1108. PubMed ID: 31373415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of the reducer: A multi-center clinical registry - REDUCE study.
    Giannini F; Baldetti L; Konigstein M; Rosseel L; Ruparelia N; Gallone G; Colombo A; Banai S; Verheye S
    Int J Cardiol; 2018 Oct; 269():40-44. PubMed ID: 29983248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study.
    Konigstein M; Ponticelli F; Zivelonghi C; Merdler I; Revivo M; Verheye S; Giannini F; Banai S
    Clin Cardiol; 2021 Mar; 44(3):424-428. PubMed ID: 33605473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus.
    Vescovo GM; Zivelonghi C; Agostoni P; Dekker M; Silvis M; Leenders G; van Kuijk JP; Timmers L; Stella P; Banai S; Verheye S
    Heart Vessels; 2022 Feb; 37(2):194-199. PubMed ID: 34374824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
    Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
    Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study.
    Palmisano A; Giannini F; Rancoita P; Gallone G; Benedetti G; Baldetti L; Tzanis G; Vignale D; Monti C; Ponticelli F; Ancona M; Montorfano M; Del Maschio A; De Cobelli F; Colombo A; Esposito A
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):291-303. PubMed ID: 32860122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study.
    Corcoran D; Ford TJ; Hsu LY; Chiribiri A; Orchard V; Mangion K; McEntegart M; Rocchiccioli P; Watkins S; Good R; Brooksbank K; Padmanabhan S; Sattar N; McConnachie A; Oldroyd KG; Touyz RM; Arai A; Berry C
    Open Heart; 2018; 5(2):e000924. PubMed ID: 30687508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter treatment for refractory angina with the Coronary Sinus Reducer.
    Konigstein M; Meyten N; Verheye S; Schwartz M; Banai S
    EuroIntervention; 2014 Feb; 9(10):1158-64. PubMed ID: 24561732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary sinus narrowing therapy: A "Reducer" for angina and beyond.
    Dimitriadis K; Iliakis P; Pyrpyris N; Beneki E; Tsioufis P; Aznaouridis K; Aggeli K; Tsioufis K
    Cardiovasc Revasc Med; 2023 Dec; 57():96-105. PubMed ID: 37573172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
    Mehta PK; Goykhman P; Thomson LE; Shufelt C; Wei J; Yang Y; Gill E; Minissian M; Shaw LJ; Slomka PJ; Slivka M; Berman DS; Bairey Merz CN
    JACC Cardiovasc Imaging; 2011 May; 4(5):514-22. PubMed ID: 21565740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
    Bairey Merz CN; Handberg EM; Shufelt CL; Mehta PK; Minissian MB; Wei J; Thomson LE; Berman DS; Shaw LJ; Petersen JW; Brown GH; Anderson RD; Shuster JJ; Cook-Wiens G; Rogatko A; Pepine CJ
    Eur Heart J; 2016 May; 37(19):1504-13. PubMed ID: 26614823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.